Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Special vein nutrient liquid for treating hundestaupe virus and parvovirus infected dog and application method thereof

A technology of canine distemper virus and parvovirus, which is applied in the direction of antiviral agents, medical preparations containing active ingredients, metabolic diseases, etc., can solve the problem of inability to meet the daily nutritional needs of sick dogs, and the inability to effectively improve the body's resistance and nutrition. Support limited effects and other issues, to improve immunosuppression and immunodeficiency, improve immune function and resistance, and promote wound healing

Inactive Publication Date: 2014-08-13
CHANGSHA LVYE BIOTECHNOLOGY CO LTD
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] For these two diseases, early rehydration is one of the key steps in the treatment, but for general veterinarians, the clinical routine rehydration is mainly to supplement glucose, but due to the single composition, it cannot meet the daily nutritional needs of dogs. The effect of nutritional support is limited, and it cannot effectively improve the body's resistance, resulting in a high mortality rate

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] 12.5g soybean oil, 12.5g medium-chain triglycerides, 3g lecithin, 3.5g glycerol, 25g compound amino acid (20AA) (purchased from Shenzhen Taier Amino Acid Biological Products Co., Ltd.), 10g N(2)-L- Alanyl-L-glutamyl (purchased from Jinan Chenghui Shuangda Chemical Co., Ltd.), 75g glucose, 1.5g potassium chloride, water-soluble vitamins (vitamin B1 is 1.5mg, vitamin B2 is 1.8mg, nicotinamide 20mg , vitamin B6 is 2.0mg, vitamin C is 50mg, vitamin B12 is 2.5μg), fat-soluble vitamins (vitamin A is 0.5mg, vitamin D is 2.5μg, vitamin E is 30mg, vitamin K is 0.075mg), 5g fish oil, 1.08g sodium glycerophosphate, 20mg deoxyglucose, 30mg oleuropein, 20mg hijiki polysaccharide. Dissolve the above components in distilled water to prepare 1000ml of intravenous injection, filter and sterilize with a 0.45μm microporous membrane, and prepare and use immediately.

[0026] Clinical Trials:

[0027] The experimental animals were 12-24 month-old dogs who were clinically diagnosed with parv...

Embodiment 2

[0030] Embodiment 2. fat-soluble substances: 12.5g soybean oil, 12.5g medium-chain triglycerides, 2.1g lecithin, 3.5g glycerol, fat-soluble vitamins (vitamin A is 0.5mg, vitamin D is 2.5 μ g, vitamin E 30mg, vitamin K is 0.075mg), 5g fish oil is mixed, and 0.45μm microporous membrane is filtered and sterilized to obtain A liquid; company), 10g N(2)-L-alanyl-L-glutamyl (purchased from Jinan Chenghui Shuangda Chemical Co., Ltd.), 75g glucose, 1.5g potassium chloride, water-soluble vitamins (vitamin B1 is 1.5 mg, vitamin B2 1.8mg, niacinamide 20mg, vitamin B6 2.0mg, vitamin C 50mg, vitamin B12 2.5μg), 1.08g sodium glycerophosphate, deoxyglucose 20mg, oleuropein 30mg, hijiki polysaccharide 20mg Dissolve in distilled water to prepare 950ml solution, filter and sterilize with 0.45μm microporous membrane to obtain liquid B. Solution A and solution B should be stored at 4°C and mixed before use.

[0031] Example 3.13g soybean oil, 13g medium-chain triglycerides, 2.1g lecithin, 3g gl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a special vein nutrient supporting liquid for treating a hundestaupe virus and parvovirus infected dog. The liquid contains heat (carbohydrates and lipid emulsion), necessary and unnecessary amino acids, vitamins, electrolytes and trace elements; besides, the liquid is also added with deoxyglucose, sargassum fusiforme polysaccharide and oleuropein with an immunity regulating function so that the basic nutritional condition of the infected dog can be still maintained even when the infected dog cannot eat foods, and the resistance to diseases is enhanced, thus the aim of increasing the cure rate of the hundestaupe virus and parvovirus infected dog and reducing deaths can be achieved.

Description

technical field [0001] The invention belongs to the field of animal medicine, and relates to a special intravenous nutrient solution for nutritional support of canine distemper virus and parvovirus-infected dogs, in particular to an intravenous nutrient solution specially used for nutritional support of canine distemper virus and parvovirus-infected dogs and its application method . Background technique [0002] Canine distemper, commonly known as canine distemper and its English name Canine distemper, is a serious canine disease that mainly harms puppies. Its pathogen is canine distemper virus. Sick dogs are characterized by biphasic fever, rhinitis, severe digestive tract disorders, and respiratory inflammation, and encephalitis can occur in a small number of cases. Canine parvovirus is an acute infectious disease caused by canine parvovirus infection in puppies. There are two clinical phenotypes, the hemorrhagic enteritis type is characterized by severe vomiting, hemor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/48A61P3/02A61P31/14A61P31/20A61K31/715A61K35/60A61K33/14A61K31/714A61K31/7004A61K31/685A61K31/59A61K31/525A61K31/51A61K31/455A61K31/4415A61K31/375A61K31/355A61K31/198A61K31/195A61K31/07A61K31/7048A61K31/661
Inventor 邬静文利新
Owner CHANGSHA LVYE BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com